Emicrania: neurologo Vernieri, ‘anticorpi monoclonali efficaci su controllo attacchi’

adnkronos

(Adnkronos) - “Le copiose evidenze real life” sull’impiego degli anticorpi monoclonali per il trattamento dell’emicrania “hanno addirittura aumentato, rispetto ai trial clinici randomizzati, i risultati in termini di efficacia, di miglioramento della qualità di vita e di riduzione della disabilità”. Così Fabrizio Vernieri, responsabile Uos Cefalee e Neurosonologia del policlinico universitario Campus Bio-Medico e professore di Neurologia dell’università Campus Bio-Medico di Roma, all’incontro ‘Empatia, empowerment, emicrania: vivere la vita’, organizzato a Roma da Organon Italia.

Transcript

00:00We are talking about real-life evidence, because randomized trial clinics have already shown

00:10the effectiveness, the tolerability, the safety of monoclonal antibodies.

00:14The real-life evidence that has happened in these years, that have become copious and

00:20that represent the results of the clinical practice that we do daily in our

00:26patients, have even increased the results in terms of effectiveness, quality of life,

00:33disability in patients treated with monoclonal antibodies.

00:38So this has valued the fact that these treatments, for the first time in a selective way,

00:44treating patients at high frequency and with chronic hemicrania, have clearly improved

00:50the quality of life of hemicranial patients.

Category

Transcript

Comments

Recommended